Vaccine Adjuvants - Global Market Outlook (2017-2026)

Vaccine Adjuvants - Global Market Outlook (2017-2026)

  • Published: January 2019
  • ID: SMRC17944

According to Stratistics MRC, the Global Vaccine Adjuvants Market is accounted for $460.21 million in 2017 and is expected to reach $1,330.25 million by 2026 growing at a CAGR of 12.5% from 2017 to 2026. Some of the factors such as the high occurrence of zoonotic and infectious syndromes, growing geriatric population and rising usage of Adjuvants in Vaccine are fueling the market growth. However, factors such as cost of adjuvant development and side effects of adjuvants are hampering the market growth. The rising usage of synthetic vaccines and recombinant sub-unit are acting as an opportunity for the market growth in the coming years.

Adjuvants are fundamentally compounds that improve the body’s immunogenic reaction against antigens. As a result, these are majorly added to vaccines to increase their capability to influence long-term protection and safety against any kind of viruses. Currently, MF59 and aluminum salts are the only adjuvants which are viable for human usage. There have been a lot of developments done on the antigen discovery over the past decade which has enhanced the vaccine development process.

Amongst Route of Administration, Intramuscular Route segment is driven by owing to rapidly rising geriatric population and vaccines for enhanced immunization are propelling the growth of this segment. These include vaccines for HPV, influenza, meningitis, etc. By geography, North America region is dominated the market during the forecast period due to factors such as higher adoption, greater knowledge about regular vaccination and presence of major market players, coupled with higher healthcare expenditure.

Some of the key players in Vaccine Adjuvants market include Viscogel AB, Vaxliant, Vaxine Pty Ltd., Sigma Aldrich (Merck KGaA), Sergeant Adjuvants, OZ Biosciences, Novavax, Inc., Novartis/CSL, MVP Laboratories, Inc., Kineta, Inc., Invivogen, GSK, CureVac AG, CSL Limited, Avanti Polar Lipids, Aphios Corp., Agenus, Inc., Adjuvatis and Adjuvance Technologies, Inc.

Products Covered:
• Pathogen Components
• Particulate Adjuvants
• Combination Adjuvants
• Adjuvant Emulsions
• Saponin
• Other Types

Disease Types Covered:
• Cancer
• Infectious Diseases
• Other Disease Types

Types Covered:
• Virus-like Particles
• Tensoactive Adjuvants     
• Organic Adjuvants
• Mineral Salt based Adjuvants  
• Liposomes            
• Emulsions         
• Carbohydrates Adjuvants       
• Bacteria-derived Adjuvants
• Other Types

Mechanism of Actions Covered:
• Vehicle Adjuvants
• Carriers    
• Active Immunostimulants

Route of Administrations Covered:
• Subcutaneous Route
• Oral Route
• Intranasal Route
• Intramuscular Route
• Intradermal Route
• Other Route of Administrations

Applications Covered:
• Veterinary Vaccine Adjuvants
• Human Vaccine Adjuvants

End Users Covered:
• Research Institutes
• Pharmaceutical Companies
• Contract Manufacturing Organization
• Commercial
• Pediatric
• Adults
• Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Company Profiling
    o Comprehensive profiling of additional market players (up to 3)
    o SWOT Analysis of key players (up to 3)
Regional Segmentation
    o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
Competitive Benchmarking
    o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary     
      
2 Preface     
 2.1 Abstract    
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology    
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions   
      
3 Market Trend Analysis     
 3.1 Introduction    
 3.2 Drivers    
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats    
 3.6 Product Analysis    
 3.7 Application Analysis    
 3.8 End User Analysis    
 3.9 Emerging Markets    
 3.10 Futuristic Market Scenario    
      
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry    
      
5 Global Vaccine Adjuvants Market, By Product     
 5.1 Introduction    
 5.2 Pathogen Components     
 5.3 Particulate Adjuvants     
 5.4 Combination Adjuvants     
 5.5 Adjuvant Emulsions     
 5.6 Saponin    
 5.7 Other Types    
      
6 Global Vaccine Adjuvants Market, By Disease Type     
 6.1 Introduction    
 6.2 Cancer    
 6.3 Infectious Diseases    
 6.4 Other Disease Types    
      
7 Global Vaccine Adjuvants Market, By Type     
 7.1 Introduction    
 7.2 Virus-like Particles    
 7.3 Tensoactive Adjuvants          
 7.4 Organic Adjuvants     
 7.5 Mineral Salt based Adjuvants       
 7.6 Liposomes                 
 7.7 Emulsions              
 7.8 Carbohydrates Adjuvants            
 7.9 Bacteria-derived Adjuvants     
 7.10 Other Types    
      
8 Global Vaccine Adjuvants Market, By Mechanism of action     
 8.1 Introduction    
 8.2 Vehicle Adjuvants     
 8.3 Carriers         
 8.4 Active Immunostimulants    
      
9 Global Vaccine Adjuvants Market, By Route of Administration     
 9.1 Introduction    
 9.2 Subcutaneous Route     
 9.3 Oral Route     
 9.4 Intranasal Route     
 9.5 Intramuscular Route     
 9.6 Intradermal Route     
 9.7 Other Route of Administrations    
      
10 Global Vaccine Adjuvants Market, By Application     
 10.1 Introduction    
 10.2 Veterinary Vaccine Adjuvants    
 10.3 Human Vaccine Adjuvants     
      
11 Global Vaccine Adjuvants Market, By End User     
 11.1 Introduction    
 11.2 Research Institutes    
 11.3 Pharmaceutical Companies    
 11.4 Contract Manufacturing Organization    
 11.5 Commercial     
 11.6 Pediatric    
 11.7 Adults    
 11.8 Other End Users    
      
12 Global Vaccine Adjuvants Market, By Geography     
 12.1 Introduction    
 12.2 North America    
  12.2.1 US   
  12.2.2 Canada   
  12.2.3 Mexico   
 12.3 Europe    
  12.3.1 Germany   
  12.3.2 UK   
  12.3.3 Italy   
  12.3.4 France   
  12.3.5 Spain   
  12.3.6 Rest of Europe   
 12.4 Asia Pacific    
  12.4.1 Japan   
  12.4.2 China   
  12.4.3 India   
  12.4.4 Australia   
  12.4.5 New Zealand   
  12.4.6 South Korea   
  12.4.7 Rest of Asia Pacific   
 12.5 South America    
  12.5.1 Argentina   
  12.5.2 Brazil   
  12.5.3 Chile   
  12.5.4 Rest of South America   
 12.6 Middle East & Africa    
  12.6.1 Saudi Arabia   
  12.6.2 UAE   
  12.6.3 Qatar   
  12.6.4 South Africa   
  12.6.5 Rest of Middle East & Africa   
      
13 Key Developments     
 13.1 Agreements, Partnerships, Collaborations and Joint Ventures    
 13.2 Acquisitions & Mergers    
 13.3 New Product Launch    
 13.4 Expansions    
 13.5 Other Key Strategies    
      
14 Company Profiling     
 14.1 Viscogel AB    
 14.2 Vaxliant    
 14.3 Vaxine Pty Ltd.    
 14.4 Sigma Aldrich (Merck KGaA)    
 14.5 Sergeant Adjuvants    
 14.6 OZ Biosciences    
 14.7 Novavax, Inc.    
 14.8 Novartis/CSL    
 14.9 MVP Laboratories, Inc.    
 14.10 Kineta, Inc.    
 14.11 Invivogen    
 14.12 GSK    
 14.13 CureVac AG    
 14.14 CSL Limited    
 14.15 Avanti Polar Lipids    
 14.16 Aphios Corp.    
 14.17 Agenus, Inc.    
 14.18 Adjuvatis    
 14.19 Adjuvance Technologies, Inc    


List of Tables      
1 Global Vaccine Adjuvants Market Outlook, By Region (2016-2026) (US $MN)      
2 Global Vaccine Adjuvants Market Outlook, By Product (2016-2026) (US $MN)     
3 Global Vaccine Adjuvants Market Outlook, By Pathogen Components (2016-2026) (US $MN)     
4 Global Vaccine Adjuvants Market Outlook, By Particulate Adjuvants (2016-2026) (US $MN)     
5 Global Vaccine Adjuvants Market Outlook, By Combination Adjuvants (2016-2026) (US $MN)     
6 Global Vaccine Adjuvants Market Outlook, By Adjuvant Emulsions (2016-2026) (US $MN)     
7 Global Vaccine Adjuvants Market Outlook, By Saponin (2016-2026) (US $MN)     
8 Global Vaccine Adjuvants Market Outlook, By Other Types (2016-2026) (US $MN)     
9 Global Vaccine Adjuvants Market Outlook, By Disease Type (2016-2026) (US $MN)     
10 Global Vaccine Adjuvants Market Outlook, By Cancer (2016-2026) (US $MN)     
11 Global Vaccine Adjuvants Market Outlook, By Infectious Diseases (2016-2026) (US $MN)     
12 Global Vaccine Adjuvants Market Outlook, By Other Disease Types (2016-2026) (US $MN)     
13 Global Vaccine Adjuvants Market Outlook, By Type (2016-2026) (US $MN)     
14 Global Vaccine Adjuvants Market Outlook, By Virus-like Particles (2016-2026) (US $MN)     
15 Global Vaccine Adjuvants Market Outlook, By Tensoactive Adjuvants (2016-2026) (US $MN)     
16 Global Vaccine Adjuvants Market Outlook, By Organic Adjuvants (2016-2026) (US $MN)     
17 Global Vaccine Adjuvants Market Outlook, By Mineral Salt based Adjuvants (2016-2026) (US $MN)     
18 Global Vaccine Adjuvants Market Outlook, By Liposomes (2016-2026) (US $MN)     
19 Global Vaccine Adjuvants Market Outlook, By Emulsions (2016-2026) (US $MN)     
20 Global Vaccine Adjuvants Market Outlook, By Carbohydrates Adjuvants (2016-2026) (US $MN)     
21 Global Vaccine Adjuvants Market Outlook, By Bacteria-derived Adjuvants (2016-2026) (US $MN)     
22 Global Vaccine Adjuvants Market Outlook, By Other Types (2016-2026) (US $MN)     
23 Global Vaccine Adjuvants Market Outlook, By Mechanism of action (2016-2026) (US $MN)     
24 Global Vaccine Adjuvants Market Outlook, By Vehicle Adjuvants (2016-2026) (US $MN)     
25 Global Vaccine Adjuvants Market Outlook, By Carriers (2016-2026) (US $MN)     
26 Global Vaccine Adjuvants Market Outlook, By Active Immunostimulants (2016-2026) (US $MN)     
27 Global Vaccine Adjuvants Market Outlook, By Route of Administration (2016-2026) (US $MN)     
28 Global Vaccine Adjuvants Market Outlook, By Subcutaneous Route (2016-2026) (US $MN)     
29 Global Vaccine Adjuvants Market Outlook, By Oral Route (2016-2026) (US $MN)     
30 Global Vaccine Adjuvants Market Outlook, By Intranasal Route (2016-2026) (US $MN)     
31 Global Vaccine Adjuvants Market Outlook, By Intramuscular Route (2016-2026) (US $MN)     
32 Global Vaccine Adjuvants Market Outlook, By Intradermal Route (2016-2026) (US $MN)     
33 Global Vaccine Adjuvants Market Outlook, By Other Route of Administrations (2016-2026) (US $MN)     
34 Global Vaccine Adjuvants Market Outlook, By Application (2016-2026) (US $MN)     
35 Global Vaccine Adjuvants Market Outlook, By Veterinary Vaccine Adjuvants (2016-2026) (US $MN)     
36 Global Vaccine Adjuvants Market Outlook, By Human Vaccine Adjuvants (2016-2026) (US $MN)     
37 Global Vaccine Adjuvants Market Outlook, By End User (2016-2026) (US $MN)     
38 Global Vaccine Adjuvants Market Outlook, By Research Institutes (2016-2026) (US $MN)     
39 Global Vaccine Adjuvants Market Outlook, By Pharmaceutical Companies (2016-2026) (US $MN)     
40 Global Vaccine Adjuvants Market Outlook, By Contract Manufacturing Organization (2016-2026) (US $MN)     
41 Global Vaccine Adjuvants Market Outlook, By Commercial (2016-2026) (US $MN)     
42 Global Vaccine Adjuvants Market Outlook, By Pediatric (2016-2026) (US $MN)     
43 Global Vaccine Adjuvants Market Outlook, By Adults (2016-2026) (US $MN)     
44 Global Vaccine Adjuvants Market Outlook, By Other End Users (2016-2026) (US $MN)     
      
NOTE:  Tables for North America, Europe, Asia Pacific, South America, and Middle East & Africa are represented in the same manner above.     

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials